Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
405
Frequently Asked Questions
What is Market Cap of Dynavax Technologies Corp.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Dynavax Technologies Corp. market cap is $1.18B.
What is the 52-week high for Dynavax Technologies Corp.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Dynavax Technologies Corp. 52 week high is $14.63 as of September 09, 2025.
What is the 52-week low for Dynavax Technologies Corp.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Dynavax Technologies Corp. 52 week low is $9.22 as of September 09, 2025.
What is Dynavax Technologies Corp. stock price today?
Dynavax Technologies Corp. stock price today is $9.70.
What was Dynavax Technologies Corp. stock price yesterday?
Dynavax Technologies Corp. stock price yesterday was $10.06.
What is the PE ratio of Dynavax Technologies Corp.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Dynavax Technologies Corp.’s P/E ratio is -21.20.
What is the Price-to-Book ratio of Dynavax Technologies Corp.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Dynavax Technologies Corp. P/B ratio is 2.3865.
What is the 50-day moving average of Dynavax Technologies Corp.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Dynavax Technologies Corp. 50-day moving average is $10.62.
How many employess does Dynavax Technologies Corp. has?
DVAX Dynavax Technologies Corp.